Package Insert: Information for the User
Fluoxetina Kern Pharma 20 mg Hard Capsules EFG
Read this package insert carefully before starting to take this medication, as it contains important information for you.
Fluoxetina Kern Pharma contains the active ingredient fluoxetine, which belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs).
This medicine is indicated for the treatment of:
Adults:
Older children and adolescents (over 8 years):
How fluoxetine works
Everyone has a substance called serotonin in their brain. People who are depressed or have obsessive-compulsive disorder or bulimia nervosa have lower levels of serotonin than others. The exact way fluoxetine and other SSRIs work is not fully understood, but they may help by increasing serotonin levels in the brain.
Treating these conditions is important to help improve your symptoms. If left untreated, your condition cannot disappear and may become more severe and harder to treat..
You may need to be treated for a few weeks or months to ensure you are free of symptoms.
Do not take Fluoxetina Kern Pharma
The treatment with Fluoxetina Kern Pharma may only be initiated after 2 weeks of completing a treatment with an irreversible non-selective MAO inhibitor.
Do not takeany IMAOirreversible non-selectivefor at least five weeks after stopping the medication with Fluoxetina Kern Pharma. If you have been prescribed Fluoxetina Kern Pharma for a long period of time and/or at a high dose, your doctor may consider the need to set a longer interval before taking an IMAO.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Fluoxetina Kern Pharma if you experience any of the following:
Thoughts of suicide and worsening of your depression or anxiety
If you are depressed and/or have an anxiety disorder, you may sometimes have thoughts of self-harm or suicide. This may increase when starting to take antidepressants, as all these medications need time to start working, usually around two weeks, although sometimes longer.
You are more likely to think this way:
- If you have previously had thoughts of suicide or self-harm.
- If you are a young adult. Information from clinical trials has shown an increased risk of suicidal behavior in adults under 25 years with psychiatric illnesses, who were treated with antidepressants.
If you ever have thoughts of suicide or self-harm,contact your doctor or go directly to the hospital.
You may find it helpful to tell a family member or close friendwho is depressed or has an anxiety disorder and ask them to read this leaflet. You can ask them to tell you if they think your depressionor anxiety is getting worse, or if they are concerned about changes in your behavior.
Sexual dysfunction
Some medications in the group to which Fluoxetina Kern Pharma belongs (called SSRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Children and adolescents aged 8 to 18 years
Children under 18 years have a higher risk of adverse effects such as suicidal behavior, suicidal thoughts, and hostility (mainly aggression, confrontational behavior, and irritability) when taking this class of medications. Fluoxetina Kern Pharma should only be used in children and adolescents aged 8 to 18 years for the treatment of moderate to severe depressive episodes (in combination with psychological therapy), and should not be used for other indications in this age group.
Additionally, there is only limited information available regarding the long-term safety of fluoxetine in relation to growth, puberty, and cognitive, emotional, and behavioral development in this age group. However, your doctor may prescribe fluoxetine to patients under 18 years for the treatment of moderate to severe depressive episodes, in combination with psychological therapy, if they decide it is in the best interest of the patient. If your doctor prescribes Fluoxetina Kern Pharma to a patient under 18 years and you wish to discuss this decision, please return to your doctor. You should inform your doctor if any of the symptoms mentioned above appear or worsen when patients under 18 years are taking Fluoxetina Kern Pharma.
Fluoxetina Kern Pharma should not be used in the treatment of children under 8 years of age.
Other medications and Fluoxetina Kern Pharma
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Do not take Fluoxetina Kern Pharma with:
The treatment with Fluoxetina Kern Pharma should only be initiated at least 2 weeks after discontinuing an irreversible non-selective MAO inhibitor (for example, tranilcipromina). Do not take any IMAO irreversible non-selective for at least 5 weeks after stopping the medication with Fluoxetina Kern Pharma. If you have been prescribed Fluoxetina Kern Pharma for a long period of time and/or at a high dose, your doctor may consider the need to set a longer interval before taking an IMAO.
Fluoxetina Kern Pharma may affect the action of other medications (interaction):
Fluoxetina Kern Pharma with food, drinks, and alcohol
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Pregnancy
Talk to your doctor as soon as possible if you are pregnant, if you think you may be pregnant, or if you are planning to become pregnant.
Studies in babies whose mothers took fluoxetine during the first months of pregnancy have described an increased risk of congenital heart defects. In the general population, approximately 1 in 100 babies are born with a heart defect. This probability increased to around 2 in 100 in those babies whose mothers took fluoxetine.
When taken during pregnancy, particularly in the last 3 months of pregnancy, medications like fluoxetine may increase the risk of a serious illness in babies, called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe faster and turn blue. These symptoms usually start within the first 24 hours after the baby is born. If this happens to your baby, contact your midwife and/or doctor immediately.
Use with caution when used during pregnancy,especially in the last stage of pregnancy or just before delivery, as the following effects have been reported in newborns: irritability, tremors, muscle weakness, persistent crying, and difficulty breastfeeding or sleeping.
It is preferable not to use this treatment during pregnancy unless the potential benefit outweighs the potential risk. Therefore, you and your doctor may decide to gradually stop taking fluoxetine Kern Pharma during pregnancy or before becoming pregnant. However, depending on your circumstances, your doctor may suggest that it is better for you to continue taking Fluoxetina Kern Pharma.
If you take Fluoxetina Kern Pharma in the final stage of pregnancy, there may be an increased risk of excessive vaginal bleeding after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking this medication to be able to advise you.
Lactation
Fluoxetine is excreted in breast milk and may cause adverse effects in infants. You should only continue breastfeeding if absolutely necessary. If you continue breastfeeding, your doctor may prescribe a lower dose of fluoxetine.
Fertility
In animal studies, fluoxetine has been shown to reduce sperm quality. Theoretically, this may affect fertility, but there has been no observed impact on human fertility.
Driving and operating machinery
Medications like Fluoxetina Kern Pharma canalter your judgment or coordination.Do not drive or operate machinery until you know how Fluoxetina Kern Pharma affects you.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.Do not take more capsules than indicated by your doctor.
Swallow the capsules with water. Do not chew the capsules.
Adults:
The recommended dose is:
Use in children and adolescents aged 8 to 18 years with depression:
Treatment should be initiated and supervised by a specialist. The initial dose is 10 mg/day (administer 2.5 ml of commercial presentations with the same active ingredient in oral solution at a concentration of 20 mg/5ml). After one or two weeks, your doctor may increase the dose to 20 mg/day. The dose should be increased carefully to ensure that the patient remains on the lowest effective dose. Children with low weight may require lower doses. Your doctor should reevaluate the need to continue treatment after 6 months. If you have not improved in 9 weeks, treatment should be reconsidered.
Older adults:
The dose increases made by your doctor should be carried out more carefully, and the daily dose should not generally exceed 2 capsules (40 mg). The maximum dose is 3 capsules (60 mg) daily.
Liver impairment:
If you have a liver problem or are using another medication that may interact with this medication, your doctor will decide to prescribe a lower dose or instruct you on how to use fluoxetine in alternate days.
If you take more Fluoxetina Kern Pharma than you should
The symptoms of overdose include: nausea, vomiting, seizures, heart problems (such as irregular heartbeat or cardiac arrest), lung problems, and changes in mental state ranging from excitement to coma.
If you forgot to take Fluoxetina Kern Pharma
If you interrupt treatment with Fluoxetina Kern Pharma
You may experience the following effects (withdrawal effects) when interrupting treatment with this medication: dizziness, a sensation of pins and needles, sleep disturbances (intense dreams, nightmares, insomnia), restlessness or agitation, unusual fatigue or weakness, anxiety, nausea, and/or vomiting (feeling sick or being sick), tremors (unsteadiness), and headache.
Most people find that the symptoms that occur when stopping treatment with fluoxetine are moderate and disappear within a few weeks. If you experience these symptoms when stopping your treatment, consult your doctor.
When stopping treatment with this medication, your doctor will help you reduce the dose gradually over one to two weeks, which will help reduce the likelihood of withdrawal effects.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
The most common side effects (very common side effects that can affect more than 1 in 10 people) are insomnia, headache, diarrhea, discomfort (nausea) and fatigue.
Some patients have experienced:
If you experience any of the side effects described above, contact your doctor immediately.
The following side effects have also been reported in patients taking fluoxetine:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from available data)
Fractures:In patients taking this type of medication, an increased risk of bone fractures has been observed.
Most of these side effects tend to disappear with continued treatment.
In children and adolescents (8 to 18 years)-Aside from the possible side effects mentioned above, fluoxetine may decrease growth or delay sexual maturation. Suicidal behaviors (suicide attempts and suicidal thoughts), hostility, mania, and nasal bleeding have also been reported frequently in children.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE point of your pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Fluoxetina Kern Pharma
Theactive ingredientis fluoxetine in the form of hydrochloride.
The other components(excipients) are: pregelatinized cornstarch.
The components of the gelatin capsule are: gelatin, titanium dioxide (E-171), quinoline yellow (E-104), and erythrosine (E-127).
Appearance of the product and content of the packaging
Fluoxetina Kern Pharma 20 mg is presented in the form of white and orange capsules.
Each standard package contains aluminum/PVC blisters of 28 or 60 capsules.
Each clinical package contains aluminum/PVC blisters of 500 capsules.
Only some package sizes may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
Kern Pharma, S.L.
Venus, 72- Pol. Ind.Colón II
08228 Terrassa - Barcelona
Spain
Date of the last review of this leaflet: June 2024
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.